Aspp1 Preserves Hematopoietic Stem Cell Pool Integrity and Prevents Malignant Transformation

Cell Stem Cell

Volumn 17, Issue 1, 2015, Pages 23-34

  Yamashita, Masayuki ^a   Nitta, Eriko ^a,b   Suda, Toshio ^a,c  

^a KEIO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ASPP1 PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; CELL DNA; CELL PROTEIN; FLUOROURACIL; HEMOGLOBIN; PROTEIN P53; UNCLASSIFIED DRUG; PPP1R13B PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER PREVENTION; CANCER SURVIVAL; CELL RENEWAL; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; EX VIVO STUDY; GENE EXPRESSION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; LYMPHATIC LEUKEMIA; MALIGNANT TRANSFORMATION; MEAN CORPUSCULAR HEMOGLOBIN; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; T CELL LEUKEMIA; THROMBOCYTE COUNT; THYMUS LYMPHOMA; UPREGULATION; ADULT STEM CELL; ANIMAL; CELL SELF-RENEWAL; CELL TRANSFORMATION; CYTOLOGY; DEFICIENCY; GENETICS; HEMATOLOGIC NEOPLASMS; KNOCKOUT MOUSE; MUTATION; PATHOLOGY; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT STEM CELLS; ANIMALS; APOPTOSIS; BONE MARROW TRANSPLANTATION; CELL SELF RENEWAL; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELLS; MICE; MICE, KNOCKOUT; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84936988643     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2015.05.013     Document Type: Article

References (53)

1. Agirre, X., Román-Gómez, J., Jiménez-Velasco, A., Garate, L., Montiel-Duarte, C., Navarro, G., Vázquez, I., Zalacain, M., Calasanz, M.J., Heiniger, A., et al. (2006). ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Oncogene 25, 1862-1870.
2. Alexandrova, E.M., and Moll, U.M. (2012). Roleof p53 family members p73 and p63 in human hematological malignancies. Leuk. Lymphoma 53, 2116-2129.
3. Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh, G.Y., and Suda, T. (2004). Tie2/angiopoietin-1 signaling regulates hematopoi-etic stem cell quiescence in the bone marrow niche. Cell 118, 149-161.
4. Beerman, I., Bhattacharya, D., Zandi, S., Sigvardsson, M., Weissman, I.L., Bryder, D., and Rossi, D.J. (2010). Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc. Natl. Acad. Sci. USA 107, 5465-5470.
5. Beerman, I., Seita, J., Inlay, M.A., Weissman, I.L., and Rossi, D.J. (2014). Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. Cell Stem Cell 15, 37-50.
6. Bergamaschi, D., Samuels, Y., O'Neil, N.J., Trigiante, G., Crook, T., Hsieh, J.K., O'Connor, D.J., Zhong, S., Campargue, I., Tomlinson, M.L., et al. (2003). iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat. Genet. 33, 162-167.
7. Bergamaschi, D., Samuels, Y., Jin, B., Duraisingham, S., Crook, T., and Lu, X. (2004). ASPP1 and ASPP2: common activators of p53 family members. Mol. Cell. Biol. 24, 1341-1350.
8. Blanpain, C., Mohrin, M., Sotiropoulou, P.A., and Passegué, E. (2011). DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell 8, 16-29.
9. Cabezas-Wallscheid, N., Klimmeck, D., Hansson, J., Lipka, D.B., Reyes, A., Wang, Q., Weichenhan, D., Lier, A., von Paleske, L., Renders, S., et al. (2014). Identification of regulatory networksinHSCs and their immediate progeny via integrated proteome, transcriptome, and DNA Methylome analysis. Cell Stem Cell 15, 507-522.
10. Corces-Zimmerman, M.R., Hong, W.J., Weissman, I.L., Medeiros, B.C., and Majeti, R. (2014). Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc. Natl. Acad. Sci. USA 111, 2548-2553.
11. de Laval, B., Pawlikowska, P., Petit-Cocault, L., Bilhou-Nabera, C., Aubin-Houzelstein, G., Souyri, M., Pouzoulet, F., Gaudry, M., and Porteu, F. (2013). Thrombopoietin-increased DNA-PK-dependent DNA repair limits hematopoi-etic stem and progenitor cell mutagenesis in response to DNA damage. Cell Stem Cell 12, 37-48.
12. Ema, H., Morita, Y., Yamazaki, S., Matsubara, A., Seita, J., Tadokoro, Y., Kondo, H., Takano, H., and Nakauchi, H. (2006). Adult mouse hematopoietic stem cells: purification and single-cell assays. Nat. Protoc. 1, 2979-2987.
13. Flach, J., Bakker, S.T., Mohrin, M., Conroy, P.C., Pietras, E.M., Reynaud, D., Alvarez, S., Diolaiti, M.E., Ugarte, F., Forsberg, E.C., et al. (2014). Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature 512, 198-202.
14. Garaycoechea, J.I., Crossan, G.P., Langevin, F., Daly, M., Arends, M.J., and Patel, K.J. (2012). Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 489, 571-575.
15. Helps, N.R., Barker, H.M., Elledge, S.J., and Cohen, P.T. (1995). Protein phos-phatase 1 interacts with p53BP2, aprotein which binds tothe tumour suppressor p53. FEBS Lett. 377, 295-300.
16. Hirashima, M., Bernstein, A., Stanford, W.L., and Rossant, J. (2004). Gene-trap expression screening to identify endothelial-specific genes. Blood 104, 711-718.
17. Hirashima, M., Sano, K., Morisada, T., Murakami, K., Rossant, J., and Suda, T. (2008). Lymphatic vessel assembly is impaired in Aspp1-deficient mouse embryos. Dev. Biol. 316, 149-159.
18. Huang, W., Sherman, B.T., and Lempicki, R.A. (2009). Systematic and integra-tive analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57.
19. Jia, Y., Peng, L., Rao, Q., Xing, H., Huai, L., Yu, P., Chen, Y., Wang, C., Wang, M., Mi, Y., et al. (2014). Oncogene iASPP enhances self-renewalof hematopoi-etic stem cells and facilitates their resistance to chemotherapy and irradiation. FASEB J. 28, 2816-2827.
20. Kim, H., Claps, G., Möller, A., Bowtell, D., Lu, X., and Ronai, Z.A. (2014). Siah2 regulates tight junction integrity and cell polarity through control of ASPP2 stability. Oncogene 33, 2004-2010.
21. Kühn, R., Schwenk, F., Aguet, M., and Rajewsky, K. (1995). Inducible gene targeting in mice. Science 269, 1427-1429.
22. Lerner, C., and Harrison, D.E. (1990). 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp. Hematol. 18, 114-118.
23. Liu, Y., Elf, S.E., Miyata, Y., Sashida, G., Liu, Y., Huang, G., Di Giandomenico, S., Lee, J.M., Deblasio, A., Menendez, S., et al. (2009). p53 regulates hemato-poietic stem cell quiescence. Cell Stem Cell 4, 37-48.
24. Marino, S., Vooijs, M., van Der Gulden, H., Jonkers, J., and Berns, A. (2000). Inductionofmedulloblastomas inp53-null mutant micebysomatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14, 994-1004.
25. Milyavsky, M., Gan, O.I., Trottier, M., Komosa, M., Tabach, O., Notta, F., Lechman, E., Hermans, K.G., Eppert, K., Konovalova, Z., et al. (2010). A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell 7, 186-197.
26. Mohrin, M., Bourke, E., Alexander, D., Warr, M.R., Barry-Holson, K., Le Beau, M.M., Morrison, C.G., and Passegué, E. (2010). Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 7, 174-185.
27. Morita, Y., Ema, H., and Nakauchi, H. (2010). Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J. Exp. Med. 207, 1173-1182.
28. Nakamura, Y., Arai, F., Iwasaki, H., Hosokawa, K., Kobayashi, I., Gomei, Y., Matsumoto, Y., Yoshihara, H., and Suda, T. (2010). Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood 116, 1422-1432.
29. Nitta, E., Yamashita, M., Hosokawa, K., Xian, M., Takubo, K., Arai, F., Nakada, S., and Suda, T. (2011). Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telo-mere-independent mechanism. Blood 117, 4169-4180.
30. Nolan, G.P., Fiering, S., Nicolas, J.F., and Herzenberg, L.A. (1988). Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc. Natl. Acad. Sci. USA 85, 2603-2607.
31. Orkin, S.H., and Zon, L.I. (2008). Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631-644.
32. Palomero, T., Couronné, L., Khiabanian, H., Kim, M.Y., Ambesi-Impiombato, A., Perez-Garcia, A., Carpenter, Z., Abate, F., Allegretta, M., Haydu, J.E., et al. (2014). Recurrent mutations in epigenetic regulators, RHOA and FYN ki-nase in peripheral T cell lymphomas. Nat. Genet. 46, 166-170.
33. Pronk, C.J., Veiby, O.P., Bryder, D., and Jacobsen, S.E. (2011). Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors. J. Exp. Med. 208, 1563-1570.
34. Quivoron, C., Couronné, L., Della Valle, V., Lopez, C.K., Plo, I., Wagner-Ballon, O., Do Cruzeiro, M., Delhommeau, F., Arnulf, B., Stern, M.H., et al. (2011). TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20, 25-38.
35. Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S., and Bonner, W.M. (1998). DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858-5868.
36. Roman-Gomez, J., Jimenez-Velasco, A., Agirre, X., Prosper, F., Heiniger, A., and Torres, A. (2005). Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J. Clin. Oncol. 23, 7043-7049.
37. Rossi, D.J., Jamieson, C.H., and Weissman, I.L. (2008). Stems cells and the pathways to aging and cancer. Cell 132, 681-696.
38. Sakata-Yanagimoto, M., Enami, T., Yoshida, K., Shiraishi, Y., Ishii, R., Miyake, Y., Muto, H., Tsuyama, N., Sato-Otsubo, A., Okuno, Y., et al. (2014). Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 171-175.
39. Samuels-Lev, Y., O'Connor, D.J., Bergamaschi, D., Trigiante, G., Hsieh, J.K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., and Lu, X. (2001). ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell 8, 781-794.
40. Schultz, L.B., Chehab, N.H., Malikzay, A., and Halazonetis, T.D. (2000). p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol. 151, 1381-1390.
41. Shlush, L.I., Zandi, S., Mitchell, A., Chen, W.C., Brandwein, J.M., Gupta, V., Kennedy, J.A., Schimmer, A.D., Schuh, A.C., Yee, K.W., et al.; HALT Pan-Leukemia Gene Panel Consortium (2014). Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 506, 328-333.
42. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., and Mesirov, J.P. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550.
43. Trigiante, G., and Lu, X.(2006). ASPP [corrected] and cancer. Nat. Rev. Cancer 6, 217-226.
44. Van Zant, G. (1984). Studies of hematopoietic stem cells spared by 5-fluoro-uracil. J. Exp. Med. 159, 679-690.
45. Walter, D., Lier, A., Geiselhart, A., Thalheimer, F.B., Huntscha, S., Sobotta, M.C., Moehrle, B., Brocks, D., Bayindir, I., Kaschutnig, P., et al. (2015). Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature 520, 549-552.
46. Wang, J., Sun, Q., Morita, Y., Jiang, H., Gross, A., Lechel, A., Hildner, K., Guachalla, L.M., Gompf, A., Hartmann, D., et al. (2012). A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage. Cell 148, 1001-1014.
47. Wang, Y., Godin-Heymann, N., Dan Wang, X., Bergamaschi, D., Llanos, S., and Lu, X. (2013). ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells. Cell Death Differ. 20, 525-534.
48. Wilson, A., Laurenti, E., Oser, G., van der Wath, R.C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C.F., Eshkind, L., Bockamp, E., et al. (2008). Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135, 1118-1129.
49. Yamashita, M., Nitta, E., Nagamatsu, G., Ikushima, Y.M., Hosokawa, K., Arai, F., and Suda, T. (2013). Nucleostemin is indispensable for the maintenance and genetic stability of hematopoietic stem cells. Biochem. Biophys. Res. Commun. 441, 196-201.
50. Yang, J.P., Hori, M., Sanda, T., and Okamoto, T. (1999). Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J. Biol. Chem. 274, 15662-15670.
51. Yoo, H.Y., Sung, M.K., Lee, S.H., Kim, S., Lee, H., Park, S., Kim, S.C., Lee, B., Rho, K., Lee, J.E., et al. (2014). A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 371-375.
52. Yoshihara, H., Arai, F., Hosokawa, K., Hagiwara, T., Takubo, K., Nakamura, Y., Gomei, Y., Iwasaki, H., Matsuoka, S., Miyamoto, K., et al. (2007). Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 1, 685-697.
53. Zhang, D., Hirota, T., Marumoto, T., Shimizu, M., Kunitoku, N., Sasayama, T., Arima, Y., Feng, L., Suzuki, M., Takeya, M., and Saya, H. (2004). Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene 23, 8720-8730.